454 related articles for article (PubMed ID: 12168065)
61. Technetium-99m tetrofosmin scintigraphy in pediatric osteogenic sarcoma.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Masala S; Tarantino U; Madeddu G; Simonetti G
Oncol Rep; 2003; 10(3):605-8. PubMed ID: 12684631
[TBL] [Abstract][Full Text] [Related]
62. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
63. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Vallabhajosula S; Nikolopoulou A; Babich JW; Osborne JR; Tagawa ST; Lipai I; Solnes L; Maresca KP; Armor T; Joyal JL; Crummet R; Stubbs JB; Goldsmith SJ
J Nucl Med; 2014 Nov; 55(11):1791-8. PubMed ID: 25342385
[TBL] [Abstract][Full Text] [Related]
64. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H
Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406
[TBL] [Abstract][Full Text] [Related]
65. The usefulness of technetium-99m tetrofosmin scan to detect non-Hodgkin's lymphoma.
Liu FY; Shiau YC; Kao A; Liang JA; Yang SN
Anticancer Res; 2003; 23(3C):2951-3. PubMed ID: 12926142
[TBL] [Abstract][Full Text] [Related]
66. Ventilation scintigraphy with lipophilic cationic compounds.
Bhatnagar A; Sawroop K; Chopra MK; Kumar N; Jaimini A; Bhatnagar A
Nucl Med Commun; 2008 Nov; 29(11):987-93. PubMed ID: 18836377
[TBL] [Abstract][Full Text] [Related]
67. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of dual use of Tc-99m-pertechnetate and Tc-99m-tetrofosmin scintigraphy for the assessment of thyroid nodules.
Bhatia N; Dhingra VK; Kumari S; Dhawan DK; Chadha VD
J Med Imaging Radiat Oncol; 2020 Apr; 64(2):189-196. PubMed ID: 32103595
[TBL] [Abstract][Full Text] [Related]
69. Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals.
Sobic-Saranovic D; Pavlovic S; Jovanovic D; Nebojsa K; Todorovic-Tirnanic M; Subotic D; Artiko V; Obradovic V
Hell J Nucl Med; 2008; 11(1):16-20. PubMed ID: 18392221
[TBL] [Abstract][Full Text] [Related]
70. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
71. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
Alexiou GA; Tsiouris S; Kyritsis AP; Fotakopoulos G; Goussia A; Voulgaris S; Fotopoulos AD
J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797
[TBL] [Abstract][Full Text] [Related]
72. Multiple metastases of soft tissue visualized by technetium-99m-methylene diphosphonate scintigraphy: a case report.
Liberatore M; Megna V; Patrizi G; Giannotti D; Semproni CP; Rebonato S; Barchetti F; Gallo P; Miscusi G
J Med Case Rep; 2014 Dec; 8():459. PubMed ID: 25529855
[TBL] [Abstract][Full Text] [Related]
73. [Extraosseous abnormalities and artifacts in skeletal scintigraphy].
Mironov SP; Ansheles AA; Shulgin DN; Sergienko VB
Vestn Rentgenol Radiol; 2016; 97(2):85-94. PubMed ID: 27522703
[TBL] [Abstract][Full Text] [Related]
74. Contemporary imaging in sarcoma.
Landa J; Schwartz LH
Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
[TBL] [Abstract][Full Text] [Related]
75. Scintigraphic evaluation of malignant melanoma lesions with Tc-99m tetrofosmin.
Alonso O; Martinez M; Mut F; Bruno J; Delgado L; Lago G; Nuñez M; Bazzano C; Espasandin J; Touya E
Clin Nucl Med; 1998 Oct; 23(10):683-5. PubMed ID: 9790043
[TBL] [Abstract][Full Text] [Related]
76. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
77. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI.
Demir H; Berk F; Memisoglu K; Arslan A; Muezzinoglu B; Erdincler RO; Isgoren S; Sarlak A; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):151-5. PubMed ID: 12043911
[TBL] [Abstract][Full Text] [Related]
78. Usefulness of (99m)Tc(V)-dimercaptosuccinic acid scintigraphy in the assessment of response to external radiation therapy in soft tissue sarcoma in Giant Snauzer dog.
Chaudhari PR; Mathe D; Balogh L; Andocs G; Janoki GA
Nucl Med Rev Cent East Eur; 2005; 8(2):150-2. PubMed ID: 16437404
[TBL] [Abstract][Full Text] [Related]
79. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K
Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287
[TBL] [Abstract][Full Text] [Related]
80. Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid camera.
Filippi L; Santoni R; Nicolì P; Danieli R; Schillaci O
Cancer Biother Radiopharm; 2009 Apr; 24(2):229-35. PubMed ID: 19409045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
